Reasons to Watch: Huntington Bancshares Incorporated (NASDAQ:HBAN), Alphabet Inc (NASDAQ:GOOGL), Sarepta Therapeutics (NASDAQ:SRPT), Transocean (NYSE:RIG)

Costamare Inc. (NYSE:CMRE) shares increased 1.91% in last trading session and ended the day at $10.12. CMRE Gross Margin is 74.80% and its has a return on assets of 4.70%. Costamare Inc. (NYSE:CMRE) quarterly performance is 57.86%.

On 20 April, Costamare Inc. (NYSE:CMRE) reported Voyage revenues adjusted on a cash basis of $119.8 million for the three months ended March 31, 2016. Adjusted EBITDA of $85.3 million for the three months ended March 31, 2016. Adjusted Net income available to common stockholders of $34.3 million or $0.45 per share for the three months ended March 31, 2016.

Huntington Bancshares Incorporated (NASDAQ:HBAN) ended the last trading day at $10.25. Company weekly volatility is calculated as 2.22% and price to cash ratio as 8.79. Huntington Bancshares Incorporated (NASDAQ:HBAN) showed a weekly performance of 3.22%.

On 20 April, Huntington Bancshares Inc. (NASDAQ:HBAN) reported first-quarter earnings of $171 million. The bank, based in Columbus, Ohio, said it had earnings of 20 cents per share. The results met Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was also for earnings of 20 cents per share.

On 22 April, Alphabet Inc (NASDAQ:GOOGL) shares moved down -5.41% and was closed at $737.77. GOOGL EPS growth in last 5 year was 11.70%. Alphabet Inc (NASDAQ:GOOGL) year to date (YTD) performance is -5.17%.

Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) reported Q1 EPS of $7.50, $0.46 worse than the analyst estimate of $7.96. Revenue for the quarter came in at $20.26 billion versus the consensus estimate of $20.38 billion.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shares increased 35.66% in last trading session and ended the day at $14.95. SRPT has a return on assets of -94.30%. Sarepta Therapeutics, Inc. (NASDAQ:SRPT) quarterly performance is 23.45%.

Sarepta Therapeutics Inc. (NASDAQ:SRPT)’s muscle wasting drug got a new lease of life on Friday after staff at the U.S. Food and Drug Administration made it necessary that an independent panel of experts on Monday make a concrete recommendation on whether the drug should be approved or not.

Transocean Ltd. (NYSE:RIG) caters to the Basic Materials space. It has a net profit margin of 10.70% and weekly performance is 11.01%. On the last day of trading company shares ended up at $10.79. Transocean Ltd. (NYSE:RIG) distance from 50-day simple moving average (SMA50) is 11.45%.

Transocean Ltd. (NYSE:RIG) will report earnings for the three months ended March 31, 2016, on Wednesday, May 4, 2016, following the close of trading on the NYSE.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *